polpram 5 mg/5 mg tvrdé kapsuly
medana pharma sa - ramipril a amlodipín - 58 - hypotensiva
otrivin plus 1 mg/ml + 50 mg/ml
haleon czech republic s.r.o., Česká republika - xylometazolín - 69 - otorhinolaryngologica
fenimax
dr. max pharma s.r.o., Česká republika - dimetindén - 46 - dermatologica
polapix 5 mg filmom obalené tablety
warszawskie zaklady farmaceutyczne polfa s.a., poľsko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
polapix 2,5 mg filmom obalené tablety
warszawskie zaklady farmaceutyczne polfa s.a., poľsko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
linatra 5 mg filmom obalené tablety
warszawskie zaklady farmaceutyczne polfa s.a., poľsko - linagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiká - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
dimtruzic 240 mg
sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata
dimtruzic 120 mg
sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata
paracetamol/ibuprofen zentiva
zentiva, k.s., Česká republika - paracetamol, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica